The CA 19-9 test may be used, along with other tests such as carcinoembryonic antigen (CEA), bilirubin, and/or a liver panel, to help evaluate and monitor a person who has been diagnosed with pancreatic cancer and is undergoing treatment.CA 19-9 is used as a tumor marker:To monitor a person's response to pancreatic cancer treatment and/or cancer progressionTo watch for pancreatic cancer recurrenceSometimes to aid in the diagnosis of pancreatic cancerCA 19-9 can only be used as a tumor marker if the cancer is producing elevated amounts of it. Since CA 19-9 is elevated in about 65% of those with bile duct cancer (cholangiocarcinoma), it may be ordered to help evaluate and monitor people with this type of cancer.The CA 19-9 test is not sensitive or specific enough to use as a screening test for cancer. It is not currently useful for detection or diagnosis by itself because non-cancerous conditions can cause elevated CA 19-9 levels. Researchers continue to investigate markers to be used alone or in combination with CA 19-9 that may be more useful for screening for and detecting pancreatic cancer in the early stages, when it is most treatable.
Sample Type - Blood
Reporting Time - 1 Day
Prerequisites - No special preparation required
Price - ₹820/-
Add to cart Go Home